Public Offering (Details) |
12 Months Ended | ||
---|---|---|---|
Oct. 14, 2020
USD ($)
$ / shares
shares
|
Dec. 31, 2020
USD ($)
$ / shares
shares
|
Aug. 24, 2020
$ / shares
|
|
Subsidiary or Equity Method Investee [Line Items] | |||
Number of units issued | shares | shares | 50,000,000 | ||
Number Of Business Days | 15 days | ||
Warrant exercise price | $ 11.50 | ||
Warrant exercisable term, after the completion of the Business Combination | 30 days | ||
Warrant exercisable term, from the closing of the public offering | 12 months | ||
Warrant expiration term | 24 months | ||
Warrants redemption description | the warrants for redemption: (i) in whole and not in part; (ii) at a price of $0.01 per warrant; (iii) upon not less than 30 days' prior written notice of redemption to each warrant holder; and (iv) if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 value per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. | ||
Warrant Redemption period | 30 days | ||
Underwriting discount | $ | $ 27,500,000 | ||
Class A common stock | |||
Subsidiary or Equity Method Investee [Line Items] | |||
Common stock par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Closing share price | $ 18.00 | ||
Public Offering | |||
Subsidiary or Equity Method Investee [Line Items] | |||
Number of units issued | shares | shares | 50,000,000 | 50,000,000 | |
Price per unit | $ 10.00 | ||
Warrant Convertible Ratio | 0.33 | ||
Closing share price | $ 10.00 | ||
Underwriting discount | $ | $ 10,000,000 | ||
Underwriting discount per unit | 0.20 | ||
Additional fee deferred discount | $ | $ 17,500,000 | ||
Additional fee deferred discount per unit | 0.35 |
X | ||||||||||
- Definition Represents amount of additional fee deferred discount. No definition available.
|
X | ||||||||||
- Definition Represents additional fee deferred discount per unit. No definition available.
|
X | ||||||||||
- Definition Number of business days. No definition available.
|
X | ||||||||||
- Definition Represents amount of underwriting discount. No definition available.
|
X | ||||||||||
- Definition Represents underwriting discount per unit. No definition available.
|
X | ||||||||||
- Definition Ratio applied to the conversion of warrant split,. No definition available.
|
X | ||||||||||
- Definition Warrant exercisable term, after the completion of the Business Combination. No definition available.
|
X | ||||||||||
- Definition Warrant exercisable term, from the closing of the Proposed Public Offering. No definition available.
|
X | ||||||||||
- Definition Warrant expiration term. No definition available.
|
X | ||||||||||
- Definition Warrant redemption period. No definition available.
|
X | ||||||||||
- Definition Description of warrants redemption. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|